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INTRODUCTION 
In the pre-antibiotic era, infective endocarditis (IE) was 
considered to be an almost uniforndy fatal disease. Even 
today, in spite of ever better medical and surgical 
treatment, endocarditis remains a potentially fatal 
disease because of complications caused by emboli- 
zation, continuing sepsis, heart failure and/or bacterial 
tisue destruction resulting in valve insufficiency, 
cellulitis, abscesses, pseudoaneurysnis, fistulas, rupture 
and/or heart block. Although modern antibiotic 
regimens alone can cure the majority of patients with 
IE, surgery is still needed in the rest. There is a clear 
distinction between native valve endocarditis (NVE) 
and prosthetic valve endocarditis (I'VE), in that moyt 
patients with PVE will require surgery. Improved 
surgical treatment has made it possible to successfully 
treat the majority of the patients with IE, be it native 
or prosthetic valve, who are not cured by niedical 
treatment alone [ 1-61, 111 a recent Swedish epidemio- 
logic study of IE, an overall mortality rate of 13?4 after 
any treatment, medical alone or medical in combina- 
tion with surgery, was reported 171. 
Surgical treatment consists of removal of the 
infected and necrotic tissue followed by reconstruction 
of the integrity of the heart and repair or replacement 
of the involved valves. The inore advanced the disease 
process, the more demanding is the surgery and the 
higher will be the operative risk. 
Many patients with IE have associated disorders 
and problems (including drug abuse) of importance 
with regard to risk of recurrence, conipliance with 
treatment regimens and prognosis. All these factors 
should be considered and allowed to influence the 
design of the treatment strategies, both medical and 
surgical. 
The results of surgery depend on many factors: the 
patient's preoperative condition, the timing of surgery, 
the specific microorganism, antibiotic treatment, surgical 
technique, including choice of methods for recon- 
struction, postoperative treatment and follon-up. 
Much remains to be learned about endocarditis 
and we predict that the cardiac surgeon will play an  
increasing role in the investigation aiid treatment of this 
disease in the future. 
AIMSIGOALS 
The task was to evaluate the present status of surgical 
treatment for endocarditis arid to produce a set of 
general reconiiiiendations to help niedical physicians 
aiid surgeons evaluate their patients and define a 
successful strategy. Our objective has not been 
necessarily to get consensus answers to all quations, but 
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to identi@ the important issues and provide advice on 
treatment strategies. Areas in need of further study have 
also been identified. 
IMPORTANT CONCEPTS AND DEFINITIONS 
IE terminology is still often poorly defined and 
confusing, and some old concepts are no longer 
relevant. It is important that agreement be reached on 
the definitions of the terms used. 
IE can be described by: degree of confidence in the 
diagnosis, causative microorganism, current level of 
activity (activewith living microorganisms; inactive- 
remote or healed), location (specific valve(s), right- or 
left-sided), degree of invasion (simple, advanced) and 
presence or absence of complications (heart, secondary 
organ, or systemic complications). These parameters 
can impact upon the surgeon’s decisions in a number 
of respects, particularly timing of surgery, type and 
duration of antibiotic treatment and reconstruction 
strategies. 
The pathology that necessitates surgery can, in and 
of itself, provide an adequate basis upon which a 
treatment strategy can be formulated, but it is clearly 
advantageous (although not always possible) to have an 
accurate assessment of the microbiological status of the 
patient at the time of surgery. Patients considered for 
surgical treatment by selection have definitive patho- 
logy and definitive or imminent complication(s). 
Confidence in the diagnosis 
Durack and coworkers have studied this subject in 
depth and have developed a well-described and 
clinically applicable system that is an improvement on 
previous diagnostic criteria systems largely due to the 
incorporation of echocardiographic findings [8] (see 
also D.T. Durack, this supplement). We recommend that 
these criteria be used in the surgical evaluation and 
reporting of IE. In the end, the majority of surgical 
cases will be classified as definite, and a few as possible. 
The main uncertainty in the surgical patient is whether 
a demonstrated pathology is caused by an unrecognized 
remote, now inactive and healed, IE, or is not due to 
IE at all. 
Causative microorganism 
Positive blood culture identification of one or more 
specific microorganisms known to be able to cause 
endocarditis in a patient with a clinical picture con- 
sistent with endocarditis is considered to be evidence 
by inference of the causative microorganism. The 
strength of the microbiological diagnosis can be 
increased by operative specimen culture of the same 
organism, but negative operative cultures do not 
significantly weaken the preoperative diagnosis, since 
the majority (end of first week 36%, end of second 
week 79% and end of third week 100%) of operative 
cultures are negative due to preoperative antibiotic 
therapy [9]. 
Active versus healed 
If there are microorganisms present in the blood, tissue 
or prosthetic valve at the time of surgery, the IE is 
considered active. In practice, only a minority of 
operative specimen cultures are positive, even in patients 
with clinically and macroscopically active disease at  the 
time of surgery, because of preoperative antibiotic 
treatment. Some patients with negative blood cultures 
still have positive growth from the explanted valve. For 
practical purposes, we recommend that the IE be 
considered active when the diagnosis has been estab- 
lished using the criteria recommended by Durack and 
coworkers within 2 months or less before surgery. 
Inactive IE is called previous or healed, provided the 
history and pathology are compatible with this diag- 
nosis and no bacteria were grown from or found a t  
histologic examination of the operative specimens. 
When there is doubt about the status of the infection, 
it should be assumed that the infection is active, because 
the potential consequences of undertreating a patient 
with endocarditis are probably significantly greater than 
the converse. 
Acute versus subacute 
The activity-related classification should not be con- 
fused with the old concepts of acute, subacute and 
chronic endocarditis, originally used to describe time 
of death after onset of the disease, within 6 weeks, 
within 6 weeks and 3 months, and later than 3 months, 
respectively. The concepts are still used, but today 
they are used to indicate the aggressiveness of the 
disease. Endocarditis with a more fulminant clinical 
picture together with an aggressive microorganism (e.g. 
Staphylococcus aureus) and advanced pathology is now 
called acute endocarditis. From a surgical standpoint, 
these terms are not very relevant. 
location 
It is obvious that location of the IE in the heart, the 
involved valves and other structures is of importance 
with respect to the pathophysiology, choice of treat- 
ment strategy and prognosis. Right-sided IE requires 
surgery less often than left-sided IE. 
Cellulitis versus abscess versus pseudoaneurysm 
Cellulitis is the result of bacterial invasion and spread in 
the tissue, resulting in necrosis but not total dis- 
integration. An abscess is a closed cavity filled with pus 
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and is the result of cell death and liquefaction. Most 
cavities seen by echocardiography and during surgery 
in patients with IE communicate with the circulation 
and should more correctly be called pseudoaneurysms 
[ 1 01. Pseudoaneurysms may represent drained abscesses 
or may be formed directly by erosion and dilatation of 
the aortic wall/annulus or mitral annulus weakened by 
infection. 
Invasion-simple versus advanced 
In simple endocarditis, the pathology is limited to the 
valve cusps or leaflets and chordae. Rupture of chordae 
is a common cause of mitral insufficiency in niitral 
valve IE. In advanced endocarditis, pathology extends 
beyond the valve cusps or leaflets, and extends into 
peri- and paravalvular structures. PVE, with the excep- 
tion of IE limited to cusps of biological prostheses, is 
regarded as advanced, since involvement of the sewing 
ring of the prosthesis and the valve annulus is the rule. 
A practical approach is as follows: if the pathologic 
tissue can be completely removed by valve cusp/leaflet 
and subvalvular apparatus excision alone, the lesion is 
rimple, but if greater debridement is necessary to 
achieve that goal, the lesion is advanced. Advanced 
pathology includes multiple valve involvement, cellulitis, 
abscesses, pseudoaneurysnis, fistulas and/or rupture. 
The concept of simple versus advanced is limited to an 
assessment of the pathologic lesion alone and does not 
take into acco~int whether complications have occurred. 
Prosthetic valve endocarditis 
PVE not limited to cusps of biological prostheses 
should be considered as advanced endocarditis, because 
removal of the valve and all suture and pledget material 
will always involve some debridenient of the annulus. 
Unless debridenient is radical [ll], early recurrence is 
to be expected. Treatment of PVE is usually much 
more demanding than treatment of simple endocarditis. 
Early PVE is defined as endocarditis occurring in a 
patient up to 1 year after previous valve replacement, 
whereas late PVE entails reoperation for endocarditis 
more than 1 year after previous valve replacement [6,7]. 
Traditionally, PVE appearing within 2 months has been 
regarded as early and PVE appearing later than 2 
months as late [12,131. Persistent and recurrent IE are 
more relevant concepts (see below). 
Homograft and autograft endocarditis 
Experience with this complication is limited. Pathology 
and treatment depend upon mode of implantation 
(subcoronary freehand intra-aortic or total root 
replacement) and when after implantation the endo- 
carditis appears. In early-onset endocarditis, suture line 
involvement can be expected, and surgery with removal 
of the homograft/autograft and replacement will prob- 
ably be necessary. After primary healing, but before 
degeneration has occurred, the pathology is expected 
to resemble that of NVE, particularly for autograft 
endocarhtis, and the chance of achieving success with 
antibiotic therapy alone or of surgery being able to be 
limited to valve replacement will be greater. Endo- 
carditis affecting an old degenerated homograft will 
always require replacement and this will always be a 
more complicated and difficult operation. 
Complicated IE 
IE can cause a myriad of complications, cardiac as well 
as extracardiac. The most common are heart failure, 
sepsis, embolization and renal failure. Local progression 
of the disease will cause destruction of cardiac structures 
and result in the pathology of advanced endocarditis 
as described above. Hemodynaniic deterioration will 
cause secondary organ failure. Eiiibolization of infected 
material will cause organ damage and peripheral 
abscesses. 
Recurrent or persistent endocarditis 
Recurrent endocarditis denotes reoccurrence of endo- 
carditis after eradication of a previous endocarditis. In 
persistent endocarditis, the endocarditis is never truly 
eradicated. During the first year after valve surgery 
for endocarditis, it can be difficult or impossible to 
differentiate between the two, unless the new endo- 
carditis is caused by a different microorganism. It  is 
expected that persistent endocarditis will have made its 
presence known during the first postoperative year, and 
endocarditis that presents later can safely be considered 
recurrent. Patients with either a history of remote/ 
previous IE, or those with acute endocarditis (par- 
ticularly staphylococcal IE) requiring surgery, do have 
an increased risk of recurrent endocarditis on the 
implanted valve compared to patients who have never 
had IE [ 1 41. 
PATHOPHYSIOLOGY 
Because of the nature of the disease, the surgeon (and 
the pathologist) are most familiar with the later and 
advanced stages of IE. Our current view on the natural 
history of the pathology observed in endocarditis is 
based on a logical progression of change5. 
The concept of non-bacterial thrombotic endo- 
carditis (NBTE) [15,16] starting on areas with damaged 
endothelium/endocardium is easy for the surgeon to 
embrace. The process of IE is initiated by blood- 
borne microorganisms adhering directly to areas with 
P e t t e r s s o n  e t  a l :  R e c o m m e n d a t i o n s  f o r  t h e  s u r g i c a l  t r e a t m e n t  o f  e n d o c a r d i t i s  3 s37 
damaged endothelium or colonizing an NBTE lesion. 
Vegetations formed by bacteria, platelets and fibrin 
grow on the surface. Material escaping from vegetations 
become emboli. Deep tissue invasion is promoted by 
bacterial toxins and results in valve cusp, leaflet and/or 
chordae destruction and/or invasion and destruction 
of perivalvular structures. The infection spreads as 
cellulitis and eventually abscesses can form. The effects 
of blood pressure and flow on the tissue weakened or 
destroyed by infection will result in formation of 
pseudoaneurysms. Drained abscesses are converted to 
pseudoaneurysms when the pus and necrotic material 
are washed away by the flow of blood. In one and the 
same cavity the infectious process can be in different 
stages of activity, working its way around the circum- 
ference of the valve in a horse-shoe fashion. Destruction 
of the aortic or mitral annulus will result in partial or 
circumferential ventriculoaortic or atrioventricular 
separation, respectively. If an abscess or a pseudo- 
aneurysm breaks through to another heart chamber, a 
fistula is formed. A breakthrough to the pericardium, a 
rupture, is usually the definitive catastrophe. As long as 
the pathology is limited to the cusps/leaflets and 
subvalvular apparatus of a valve, it is, from the surgical 
point of view, simple endocarditis. As soon as the 
pathology involves a valve prosthesis or goes beyond 
the valve cusps, leaflets or subvalvular apparatus into 
perivalvular structures, it is advanced endocarditis. A 
rather common but favorable form of two-valve 
endocarditis is the appearance of a secondary/drop/jet 
lesion on the anterior mitral leaflet in cases of aortic 
valve endocarditis. Such secondary lesions can often be 
excised and the valve leaflet repaired with a pericardial 
patch. In aortic valve endocarditis, the perivalvular 
invasion often begins under the commissures. From 
there, annular destruction spreads around the root on 
top of the interventricular septum and underneath the 
pulmonary artery into areas previously occupied by 
periaortic and epicardial fat. Proximal tissue loss caused 
by invasion and necrosis of ventricular muscle is less 
common but when it occurs surgical reconstruction 
will be a more difficult problem to solve. In the area 
around the central fibrous body, invasion and pene- 
tration of the atrial septum may occur. If the infectious 
process enters into the triangle of Koch, atrioventri- 
cular node and His bundle destruction may result in 
heart block. 
ECHOCARDIOGRAPHIC EVALUATION OF 
ENDOCARDITIS 
Doppler echocardiography (transthoracic and transeso- 
phageal) is an essential component of state-of-the- 
art management of endocarditis. Echocardiography 
has developed into a central tool in the diagnosis 
of endocarditis [8]. Modern echocardiography, and 
especially the multiplane transesophageal method, has 
widened the understanding of the pathology associated 
with endocarditis [ 10,171. The surgeon can be provided 
with a more precise description of the pathology before 
the operation. The possibility for the surgeon to 
prepare a well-conceived strategy for treatment before 
entering the operating room can be invaluable, and in 
advanced cases even life-saving. 
A transesophageal echocardiographic study should 
be performed preoperatively on all patients with 
endocarditis [17]. The diagnostic gain from the 
transesophageal examination is greatest in PVE [18]. 
Endocarditis is a dynamic/progressive disease and the 
pathology changes with time, so the echocardiographic 
study should be current. In the initial stages of 
management, echocardiography in some patients needs 
to be repeated daily to show any change or progression 
in the pathologic state, particularly with staphylococcal 
IE. The differential diagnosis of advanced versus simple 
endocarditis should be made preoperatively, so that the 
patient can be referred to a surgeon with experience in 
the treatment of advanced endocarditis if necessary. 
The preoperative evaluation should be supple- 
mented with intraoperative studies and early post- 
operative study in cases with suspected persistent IE. In 
patients with a valve prosthesis, echo shadows can make 
it difficult to accurately assess the pathology, but usually 
this can be overcome by optimal use of each of the 
imaging modalities: transthoracic, transesophageal and 
epicardial. 
GENERAL PRINCIPLES FOR TREATMENT OF 
ENDOCARDITIS 
The first step is a precise microbiological and patho- 
logic diagnosis. Three separate blood cultures should be 
taken from different venipuncture sites at least 1 h apart. 
In acute endocarditis, antibiotic treatment should be 
started within 2 h, and within this time period three 
blood cultures should be obtained [19]. Recom- 
mendations are available for each specific organism 
[20]; see also this supplement. 
Close monitoring of the patients clinically and 
with serial echocardiographic studies and optimal 
timing (early rather than late) of the surgical inter- 
ventions is very important. The two primary goals of 
cardiac surgical intervention are removal of all infected 
and necrotic tissue by radical debridement and recon- 
struction of the heart. Optimal reconstruction entails 
restoring normal anatomy and valve function at low 
operative risk. Operative risk is related to the condition 
of the patient, the pathology and the ability and 
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experience of the surgeon and team. The major short- 
term risk is persistent infection. Long-term risks are 
recurrent IE and valve-related complications. The risk 
of persistent and recurrent IE is related to antibiotic 
treatment, surgery, method of reconstruction and 
patient factors (e.g. intravenous drug abuse, reduced 
immune defense). Drug abuse and HIV infection do 
not, however, contraindicate surgery [21-231. 
Mistakes often made in the management of IE are: 
0 inadequate blood cultures to secure the diagnosis 
0 delay in the commencement of antibiotics; 
0 delay in the referral to the primary cardiac physician; 
0 delay in the referral to the surgeon; 
0 failure to perform early surgery; 
0 inadequate debridement at surgery; 
0 inadequate postoperative antibiotic treatment to 
minimize persistent IE; 
0 failure to eradicate the possible focus for infection, 
including patient education to prevent recurrent IE. 
before commencement of antibiotics; 
INDICATIONS FOR SURGERY, TIMING AND 
CONSIDERATIONS 
The overall mortality of bacterial endocarditis remains 
high. Figures ranging from 21% to 50% have been 
reported in the past [24-261. A recent study reported a 
rate of 19%, in a cohort of 135 patients [27]. Mortality 
varied among NVE, endocarditis in intravenous drug 
users (IVDUs), and early and late PVE, with rates of 
23%, 7%, 14% and 18% respectively. The major cause 
of death was congestive heart failure, followed by sepsis 
and embolic events. Mortality was also influenced by 
the microbial etiology of endocarditis. Polymicrobial 
infection and Staphylococcus aureus endocarditis were 
associated with the highest overall mortality (43% and 
28% respectively). Mortality was significantly greater 
among the medically treated patients than among 
the surgically treated patients, i.e. 24% versus 9%. 
However, it should be outlined that the mortality 
atnong tnedically treated patients decreased to 15% 
when the 10 patients who were too unstable to be 
operated on or who refused surgery were excluded. 
Then, the difference in mortality between the two 
groups was no longer significant. In recent reviews, the 
mortality among medically treated patients versus 
surgically treated ones was 27% versus 11% in NVE 
[24], 56% versus 23% in PVE [28] and 40% versus 20% 
in both NVE and PVE [25]. Clearly, therefore, surgery 
is able to significantly improve the prognosis of bacterial 
endocarditis. 
Indications for surgery are now more precisely 
defined than in the past. This is due to: (1) experiences 
showing a significant improvement in the prognosis 
when surgery is combined with medical therapy; and 
(2) the use of echography and especially transeso- 
phageal echo (TEE), which helps in the analysis of the 
consequences of infection on heart structures and 
functions. 
Surgery is needed in around 30% of the cases 
during the acute phase of infection, and in another 
20-40% in secondary phases [27,29-311. 
Early surgery is now frequently considered, as it 
appears that the prognosis is much better when cardiac 
condition has not deteriorated too severely 132-341. It  
has also to be noted that the final outcome is not much 
influenced by the duration and intensity of current 
antibiotic therapy prior to surgery, a point that can help 
to decide an early surgical operation. 
There is agreement throughout the literature that 
surgical indications should be based on a careful daily 
clinical and microbiological surveillance of the patient 
and on the data provided by echography [35]. 
From a pragmatic point of view, indications can be 
divided into the following four categories, according to 
the data in the literature and to a consensus within the 
group. 
Absolute indications 
These indications are considered to be clearly estab- 
lished, as long as the prognosis remains very poor in the 
absence of surgery. 
Cardiac failure 
Cardiac failure was reported in 38% of the patients 
described by Sandre and Shafran [27], a figure con- 
sistent with the 22-7196 reported in other series. It 
represents 60% of deaths during early IE and 60-90% 
of indications for surgery [36]. The mortality due to 
cardiac failure ranges between 50% and 90% [33,37]. 
Cardiac failure secondary to aortic insufficiency is 
generally considered to be severe and rapidly pro- 
gressing [38]. A reduction of mortality due to cardiac 
failure by surgery has been clearly demonstrated, with 
figures such as 56% and 11% [39]. 
Stages 111 and IV of the New York Heart Associa- 
tion (NYHA) 1401 or conditions during which intra- 
venous vasoactive drugs or inotropic drugs other than 
digoxin are needed are considered as early indications 
for surgery within a few hours or very few days. 
Unnecessary postponement of surgical therapy exposes 
the patient not only to the risk of further hemodynamic 
deterioration, but also to the risk of progression of the 
pathology into perivalvular structures and other 
complications. Stroke, heart failure and progression of 
the disease to the advanced stage have a serious negative 
effect on prognosis [41-421. 
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Valve obstruction 
Mechanical obstruction of prosthetic valves or the 
native mitral valve by large vegetations or thrombi is a 
very urgent indication [44]. 
Definite perivalvolar abscess(es) and aneurysm of the sinus 
of Valsalva [45,461 
Patients with aortic prosthetic valves with staphylo- 
coccal infection are at high risk of developing these 
complications. Electrocardiograms showing conductive 
abnormalities and especially TEE are the main tools for 
the detection of these complications 1171. 
Non-candida fungal endocarditis 
As the mortality without surgery is around 90-loo%, 
e.g. for aspergillus endocarditis, these infections should 
be operated on, if the diagnosis is established [47]. 
Pseudomonas infection on prosthetic valve 
Because of the extreme difficulty of curing these 
infections with antibiotics alone, surgery must be 
considered, although late treatment failures have been 
described after surgical treatment [48]. 
Relative indications 
These indications are considered to need case-to-case 
discussion. 
Perivalvular abscess on TEE or isolated conductive 
abnormality on EGG 
The possibility of these should be especially monitored 
in order not to miss the period for surgery. 
Persistent bacteremia 
This phenomenon indicates a true failure of antibiotic 
therapy, provided that this treatment can be considered 
as being theoretically adapted on the basis of in vitro 
tests, and prescribed at optimal doses, in the absence 
of an extracardiac source of bacteremia. The delay 
necessary to identifi such a situation as a failure is 
considered to be more than 7 days after initiation 
of therapy [49]. Under these conditions, persistent 
bacteremia is accompanied by increased mortality [39]. 
Similarly, a relapse observed after medical therapy of 
infection due to multiresistant enterococci is considered 
to be an indication for surgery [50]. 
Early infection on prosthetic valve 
Despite the general acceptance of a number of 
published criteria describing indications for surgical 
therapy of infection on a prosthetic valve, it is often 
difficult to decide the extent to which these criteria are 
applicable in an individual case. The microbial etiology 
of early PVE is dominated by staphylococci, Staphylo- 
coccus epidermidis and Staphylococcus aureus accounting for 
about 30% and 20% of the cases respectively [51]. In 
nearly all patients, infection spreads behind the site of 
attachment of the valve prosthesis, resulting in valve 
ring abscesses and valve dehiscence in 60% of cases. The 
clinical course tends to be frequently hlminant, with 
rapid deterioration of the hemodynamic condition. 
The mortality in the absence of surgery is around 
5047%. In the paper published by Yu et a1 [28],  the 
mortality rate in the surgical group was 23%, while it 
was 56% (p<0.01) in the group ofpatients that received 
only medical therapy. Surgical therapy was associated 
with a better outcome even after stratification for 
degree of dness among the not critically ill patients. 
Surgery must be considered in cases of dysfunction of 
the prosthetic valve, occurrence of a new murmur, 
persistently positive blood cultures (see above), abnormal 
conduction on ECG, and abnormal echocardiogram 
showing vegetations greater than 2 cm in size [51]. 
Staphylococcal infection on a left-sided prosthetic valve 
is considered to be a major indication for surgery. 
In contrast, medical therapy can be considered 
under close monitoring, in case of non-virulent 
bacteria, with a normal transesophageal echography. 
Candida endocarditis 
Fungi are responsible for 9.6% of cases of early PVE 
and 4.3% of late cases. The consensus in the current 
literature is to treat fungal PVE with surgical replace- 
ment followed by antifungal therapy [52-541. It is 
noteworthy that there are several reports of patients 
with candida endocarditis being successfully treated 
with medical therapy alone [55]. In the latter paper, the 
authors suggest that, for uncomplicated PVE, the 
optimal management remains uncertain. However, 
antifungal therapy alone appears to be a reasonable 
option for patients in whom surgery is considered 
unduly hazardous. The outcome is hghly dependent 
on cardiac function and conduction status at  the onset 
of specific therapy. As late failures are possible after 
surgical therapy [56], a 2-year period of therapy with 
oral fluconazole after a total dose of 2 g of ampho- 
tericin B is recommended [55]. 
Debatable indications 
These indications are not clearly established, due to the 
limited number of cases in the literature. 
Difficult-to-treat organisms 
The following microorganisms may raise difficulties in 
medical therapy: pseudomonas infection on the native 
valve [57], Brucdla, Coxiella [58,59] and bacteria belong- 
ing to the HACEK group on the prosthetic valve. 
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Multiresistant enterococci may be considered as 
difficult-to-treat organisms. 
large vegetations 
There is no consensus for indications based on the size 
of the vegetation. However, vegetations greater than 
1 cin [60] on the mitral valve, vegetations increasing 
in size during antibiotic therapy or kissing vegetations 
on the niitral valve may raise the question of 
surgery and, in any case, represent a major reason for 
close monitoring of the patient. It remains to be 
established whether mobile vegetations should be 
resected 161 J. 
Emboli 
Ernbolic events represent one of the major compli- 
cations of bacterial endocarditis, and are observed in 
around 40% of cases [27]. The recurrence of emboli, 
observed in 40% of cases aniong patients with uncon- 
trolled infection on adequate therapy, may represent an 
indication for surgery. Emboli are more frequent with 
Staphylococcus atireus infections. Vegetations associated 
with emboli are more frequent with Streptococcus 
viridans infections. The risk of emboli decreases with 
time during efficient antibiotic therapy [62]. This point 
should be considered in the decision of whether to 
operate. 
late prosthetic valve endocarditis 
In the paper published by Sandre and Shafran [27], 
surgery was needed in 33% of late PVE cases. The type 
of bacteria involved must be considered. The prognosis 
has been significantly improved by progress in surgical 
techniques 163-651. 
Special cases 
Patients with cerebral infarction 
Evaluation and management of patients with neuro- 
logic symptoms, occurring in up to 40% of patients 
with IE, represents another difficult and controversial 
area. The surgeon has two concerns; the first is related 
to the immediate risk of intracranial bleeding during 
cardlopulmonary bypass and the second comprises the 
Thort- and long-term risk of anticoagulation. Embolic 
stroke is the most common complication. Hemorrhage 
from rupture of a mycotic aneurysm or septic arteritis 
artery occurs less often but entails a higher operative 
risk and a higher risk associated with anticoagulation. 
Since the majority of patients with IE and cerebral 
symptoms have neither bleeding nor mycotic aneurysms, 
it is not possible to give firm recommendations about 
the necessary preoperative evaluation. We recommend 
that a preoperative CT scan of the brain be done 
on every patient with neurologic symptoms. In the 
absence of a hemorrhagic infarction, valve replacement 
can be performed at least 72 h after the accident, with 
a low risk of perioperative stroke. Suspicion of 
hemorrhage is an indication for spinal fluid examina- 
tion. Cerebral angiography is required to further 
evaluate patients with intracranial hemorrhage. Patients 
with a hemorrhagic infarction clearly have an increased 
risk of intracranial bleeding during surgery, and we 
recommend that surgery, if possible, is delayed for 1 
week in these patients. 
Benefits versus risks should be carefully analyzed. 
More generally, a cerebral CT scan should be per- 
formed before cardiac surgery only when clinically 
indicated [66]. 
Visceral abscess 
When a visceral abscess (e.g. a splenic abscess) has been 
diagnosed, it should be treated before cardiac surgery. 
Elderly patients 
There is little information in the literature on the 
specific aspects of surgical indications during bacterial 
endocarditis occurring in elderly patients. However, 
the studies published by Dietrich et a1 1671 and 
Jamieson et a1 [68] indicate that cardiac valve replace- 
ment is possible in patients over 65 years of age, 
with good long-term results. Indications should be 
discussed, taking into account the general condition of 
the patient, underlying diseases, and social life aspects. 
PREOPERATIVE TREATMENT 
Preoperative treatnient has to be discussed in close 
relation to the timing of and indications for surgery. 
Treatment of the infection should be preceded by the 
proper diagnostic measures, and treatment of com- 
plications should be prompt. I t  is important that the 
patient is treated with an efficient antibiotic regimen at 
the time of surgery to kill circulating niicroorganisms. 
If there is a clear indication for surgery, there is no 
evidence that postponing the operation to allow a 
longer period of preoperative antibiotic treatment is 
beneficial. In cases of moderate valve insufflciency and 
good heart function, preoperative cure of the infection 
reduces the risk of recurrent IE [6Y] and might, at  least 
in theory, increase the likelihood that successfd valve 
repair can be perforrned later. When conservative 
surgery and valve repair are planned, adequate anti- 
biotic therapy for at  least 1 week preoperatively is 
recommended [70]. 
SURGICAL TECHNIQUE 
Before starting the operation, the surgeon must be sure 
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that he has the necessary experience and ‘tools’ to 
perform a successful operation, particularly if the 
patient has advanced pathology. General basic surgical 
principles are used to guide the surgical strategy, the 
management of the infectious pathology and the choice 
of reconstruction. 
If the infection is limited to the valve cusps or 
leaflets (simple endocarditis), their removal will have 
achieved the goal of complete debridement, and 
standard valve replacement should be sufficient therapy. 
However, if the infection extends beyond the valve 
cusps or leaflets (advanced endocarditis), radical 
debridement will be required and this will obviously 
necessitate more demanding reconstructive procedures. 
Debridement 
Complete removal of all infected and necrotic tissue 
sounds easy but requires significant experience and 
sometimes courage. Safety requires good exposure. 
Representative material is sent for microscopy and 
culture. The experience with the Ross operation for 
patients with IE has underlined the value and 
importance of good exposure in surgery for advanced 
IE 14,711. Consideration is given to the anatomy and 
available and planned methods of reconstruction, but, 
in cases of conflict of interests, radical removal of the 
pathology usually, but not always, has priority. The 
necrotic infectious tissue is removed by excision and 
curettage. Removal of the pathologic tissue is followed 
by generous rinsing of the field with saline. There is 
no evidence that local use of antiseptic or antibiotic 
solutions is of any value. Implantation of a valve 
prosthesis or a composite graft probably requires a 
sterile field to pr&ent persistent infection, whereas a 
homograft or autograft inserted without the use of felt 
might be more tolerant of residual bacteria, based on 
the lower rate of reinfection observed in most series 
with these modalities [1,2,4,71]. 
Methods for reconstruction 
The available options are valve repair (occasionally 
removal of the tricuspid or the pulmonary valve) or 
valve replacement with a valve prosthesis, mechanical 
or biological, a homograft or an autograft. In cases with 
advanced pathology, additional reconstruction or 
conduit may be required. The heart defect, the patient 
and the surgeon’s experience are all of importance with 
regard to the choice of method for reconstruction. 
Although the use of homografts for aortic valve 
replacement is followed by the lowest recurrence rate 
up to 5-10 years [1,2], the data are not strong and 
convincing enough to justifj. a general recom- 
mendation always to use homografts in all cases of 
aortic valve endocarditis, since good results, even in 
cases with advanced pathology, have been achieved 
with reconstructions including a mechanical or bio- 
logical valve prosthesis [3,72]. Insertion of a homograft 
is technically more demanding, supply is limited, 
durability is limited, and, in patients who can be 
expected to outlive their homografts, the reoperations 
will be demanding. Concerning the risk of recurrent 
endocarditis, a comparison of biological and mech- 
anical valve prostheses favored the mechanical valve 
prosthesis as having a lower risk [73]. 
Irrespective of the choice of method for recon- 
struction, the areas with active infection should, 
whenever possible, be allowed drainage either to the 
pericardium or to the circulation and not be walled in 
or ‘wallpapered’ over by the reconstruction. 
Simple endocarditis 
In patients with simple endocarditis where the 
pathology is confined to valve cusps or leaflets, all 
methods of repair or valve replacement are useful and 
the choice of one alternative or the other follows the 
normal principles for valve surgery. When possible, 
preservation of the native valve is considered to be the 
treatment of choice. This is most often possible in cases 
of tricuspid or mitral IE. Good results have been 
achieved with a conservative approach to the mitral 
valve pathology [70,74]. The usual reconstructive 
techniques have been applied. The desire to preserve 
the valve occasionally requires a more conservative 
approach to the debridement of vegetations on the 
valve cusps or leaflets, thereby relying more on the 
ability of the antimicrobial treatment to eradicate the 
infection. A defect in a valve cusp or leaflet may be 
repaired with a pericardial patch. The pulmonary valve 
may be replaced with a homograft (preferably pul- 
monary). For tricuspid valve endocarditis, there are no 
good alternatives currently available. A valve prosthesis 
will require anticoagulation and will have a high risk of 
recurrent endocarditis. Provided the pulmonary pressure 
and vascular resistance are normal, the surgeon may 
consider removal without replacement of the tricuspid 
or the pulmonary valve, but not both. The use of a 
homograft in the mitral and tricuspid positions is 
experimental. The judgment of whether a remaining 
valve insufficiency is acceptable or not can be difficult. 
Surgeons with experience in the evaluation of aortic 
and mitral valve competency after repair will apply the 
usual criteria in patients with IE. The use of peri- 
operative transesophageal echocardiography is manda- 
tory. 
Advanced endocarditis 
Following the completion of debridement, the patho- 
logy, anatomy and anatomic defects of the heart have 
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to be fully understood before a method of recon- 
struction can be chosen. The surgeon has to choose a 
method which carries an acceptable operative risk, 
carries a low risk of recurrent endocarchis and takes 
into consideration the patient’s ability to comply with 
short- and long-term medical regimens. A surgical 
technique that allows drainage of infected cavities to 
the circulation or pericardium is desirable. 
Advanced aortic valve endocarditis 
The pathology, anatomy and integrity of the left 
ventricular outflow tract has to be fully understood 
before reconstruction can begin. For patients with 
aortic valve endocarditis, the majority of publications 
favor aortic homograft (cryopreserved or antibiotic- 
sterilized) root replacement, which has an acceptable 
operative risk and gives excellent short- and medium- 
term results with a very low incidence of recurrent 
endocarditis [1,2,75]. Long-term results with homo- 
graft root replacement are important, since many of the 
IE patients are young and will require reoperations. In 
recent years, autograft root replacement (Ross opera- 
tion) has been proposed as an alternative [4,71]. Since 
experience with the Ross operation for IE is still 
limited, its general use is not recommended. Never- 
theless, the Ross operation provides unparalleled 
exposure of the pathology and has given new insights 
into advanced IE pathology [76]. Excellent results 
have also been produced with alternative methods of 
reconstruction based on the use of ordinary mechanical 
valve prostheses, composite grafts and pericardium 1771. 
Homograft or autograft insertion. Following debridement, 
the subannular tissue loss and the need for recon- 
struction should be estimated. Important points of 
orientation are the two trigones, the central fibrous 
body and the lateral trigone, on either side of the 
anterior initral leaflet. Usually, these represent the level 
of the proximal suture line for a homograft or autograft. 
Sizing of the left ventricular outflow tract is important 
to guide the choice of homograft size or the decision 
regarding whether a Ross operation is feasible or not. 
Good results have been obtained with the use of an 
interrupted as well as with a continuous suture 
technique for the proxinial suture line. From a 
theoretical point of view, the use of foreign material 
should be kept to a minimum, and monofilament 
polypropylene may have an advantage over other suture 
material. When, occasionally, extra material is required 
to reconstruct a proximal tissue defect, pericardium 
niay be used or an aortic homograft may be rotated to 
allow use of the mitral leaflet of the homograft. A 
secondary drop/jet lesion on the anterior mitral valve 
in cases with aortic valve endocarditis is not an 
uncommon pathology and is often suitable for excision 
and autologous pericardial patch repair. 
Aortic valve and root reconstruction with valve prosthesis or 
composite graft. Before reconstruction is started, every 
effort should be made to ensure a sterile operative field. 
The value of local antiseptic or antibiotic solutions to 
clean the field or impregnate prosthetic material 
remains to be proven. In cases of active infection and 
infectious pathology, an even greater effort to obtain 
the optimal conditions for insertion of a prosthesis will 
be required. In cases with a subannular, annular or 
supra-annular tissue defect, the best available material 
for reconstruction is autologous pericardium, which is 
sutured with continuous polypropylene sutures 1781. 
Valve sutures must be anchored well in living tissue, 
even if this means that the conduction system is 
jeopardized. Heart block is a common complication 
[72,79]. Suturing is more demanding when active 
disease is present, and, in these cases, the majority of 
surgeons with experience in the treatment of these 
patients favor the homograft alternative. However, it 
has been demonstrated that advanced reconstructions 
including a mechanical prosthesis can produce good 
results [72,81]. 
Advanced mitral valve endocarditis 
In cases of annular involvement, careful and complete 
debridement is critically important. To achieve this 
primary goal and to understand the pathology and 
surgical anatomy, good exposure is important. The 
choice of approach to obtain exposure depends on the 
pathology, whether there is involvement of other valves 
(usually the aortic), and the surgeon’s preference. There 
is no excuse for bad exposure. Annular defects are best 
reconstructed with autologous pericardiuin sutured 
with running polypropylene sutures [81]. Closed-off 
cavities niust be opened and made sterile. The valve 
prosthesis niust be well anchored to the ventricular inlet 
myocardium over its entire circumference; no sub- 
valvular cavities must remain, and neither must signi- 
ficant mobility of the valve be allowed when the valve 
is sutured to a reconstructed pericardial annulus. In 
cases where both the initral and the aortic valves are 
replaced with prosthetic valves, an aortic-Initral curtain 
with some elasticity to absorb the mechanical stress 
between the two prostheses must be re-established; this 
is best done with autologous pericardium [82]. The use 
of the mitral homograft may become an option but is 
still experimental [83]. 
PVE 
Radical debrideinent in these case7 means reinoval of 
all foreign material: prosthesis, pledgets and suture. 
P e t t e r s s o n  e t  a l :  R e c o m m e n d a t i o n s  for t h e  s u r g i c a l  t r e a t m e n t  o f  e n d o c a r d i t i s  3 5 4 3  
Pledgets can be deeply embedded in annular fibrous 
tissue. Good exposure is important. Aortic PVE con- 
stitutes an argument for choosing homograft [84] or 
autograft [76] reconstruction, although success is also 
possible in the most difficult cases with a reconstruction 
including the use of autologous or bovine pericardium 
and mechanical valves [85]. 
Right-sided endocarditis 
The approach should be conservative. The best possible 
repair should be attempted with minimal use of foreign 
material [86,87]. The right ventricle can usually 
manage with one good valve, provided the pulmonary 
vascular resistance and pressure are normal. The 
pulmonary valve is best not replaced, or replaced 
with a pulmonary homograft. The tricuspid valve is 
debrided conservatively and repaired as well as possible 
with autologous pericardium. If valve replacement is 
considered necessary, anticoagulation is recommended, 
whether a biological or a mechanical prosthesis is used. 
Tricuspid valve replacement with a mitral homograft is 
anecdotal. 
INFECTIVE ENDOCARDITIS IN CHILDREN 
Children with congenital heart disease develop IE both 
prior to and following cardiac surgery, whether the 
surgery is corrective or palliative. The feasibility of the 
application of the same treatment principles as in 
adult patients has been well demonstrated, including 
debridement of infected tissue and repair of the 
congenital heart defect [88,89]. 
POSTOPERATIVE TREATMENT 
Postoperative antibiotic treatment should ensure eradi- 
cation not only of the cardiac infection but also of 
metastatic and primary infectious foci. With radical 
debridement and use of homograft or autograft recon- 
struction, we believe that the cardiac infection does not 
require long-term (more than 2 weeks) postoperative 
antibiotic treatment. Patients with PVE, staphylococcal 
or fungal IE, operated on with use of a prosthetic 
valve or other foreign material, and especially when 
operative specimens are positive, require intense long- 
term (at least 6 weeks) treatment. The duration of the 
postoperative treatment should be influenced by the 
severity of the pathology found at surgery. Patients with 
clinical symptoms and/or pathology indicating active 
disease should be treated in the same way irrespective 
of culture-negative operative specimens. Patients with 
clinical, laboratory and operative findings consistent 
with inactive, healed IE do not require prolonged 
antibiotic treatment but are given ordinary peri- 
operative prophylaxis. Possible foci for infection should 
be eradicated. Since patients who have had IE have a 
greater risk of a second IE episode, patient education is 
extremely important with respect to prophylaxis against 
recurrent endocarditis. Patients operated on for fungal 
endocarditis should perhaps be given indefinite anti- 
biotic prophylaxis. Studies to hrther clarify these issues 
are required. 
AREAS FOR FUTURE RESEARCH 
0 Refinement of the diagnosis of IE; particularly the 
use of echocardiography in the description of the 
pathology. 
0 Indications for surgery in patients with vegetations 
and embolization. 
0 Optimal evaluation and management of patients 
with neurologic symptoms and timing of surgery. 
0 Optimal timing of surgery in relation to preoperative 
antibiotic treatment. 
0 Refinement of the surgical technique, debridement 
and methods of reconstruction. 
0 The use of the pulmonary autograft in patients with 
IE . 
0 Development of homografts and xenografts for 
mitral and tricuspid valve replacement. 
0 The duration of the postoperative antibiotic treat- 
ment necessary in different situations. 
GENERAL COMMENTS 
Before embarking upon surgery on patients with IE, 
an accurate assessment of the pathology should be 
obtained by state-of-the-art echocardiography. 
Cases of simple endocarditis are usually fairly 
straightforward and surgery can be performed by most 
cardiac surgeons, but advanced endocarditis requires 
the attention of surgeons who have mastered advanced 
valve surgery. It is our belief that the advanced cases, 
particularly those with perivalvular invasion and 
destruction, should be concentrated in larger centers 
with special interest in the treatment of these patients. 
Understanding the surgical anatomy of endocarditis is 
a condition for success. If the debridement is perfect 
and results in a sterile field, the choice of method 
for reconstruction, prosthetic valve versus homograft/ 
autograft, seems to be less crucial. Although most 
surgeons today favor homografts for aortic recon- 
struction, it is possible to achieve good results with 
methods using ordinary prosthetic valves. No patient 
who is not inoperable for non-cardiac reasons should 
be allowed to die from cardiac complications fkom IE 
without surgery. Today, the results after surgery for even 
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very advanced IE are excellent, with an operative 
mortalitv below 10%. 
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